BofA/Merrill Lynch Starts Durata Therapeutics (DRTX) at Buy

August 13, 2012 8:25 AM EDT Send to a Friend
Get Alerts DRTX Hot Sheet
Price: $24.16 --0%

Rating Summary:
    6 Buy, 6 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 21 | Down: 43 | New: 52
Trade DRTX Now!
Join SI Premium – FREE
BofA/Merrill Lynch initiates coverage on Durata Therapeutics (NASDAQ: DRTX) with a Buy. PT $12.00.

For an analyst ratings summary and ratings history on Durata Therapeutics click here. For more ratings news on Durata Therapeutics click here.

Shares of Durata Therapeutics closed at $7.35 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Merrill Lynch, Bank of America

Add Your Comment